JCY International Berhad (KLSE:JCY)
Malaysia · Delayed Price · Currency is MYR 0.5450
+0.0150 (2.83%)
At close: Sep 25, 2026
JCY International Berhad Revenue
JCY International Berhad had revenue of 179.15M MYR in the quarter ending June 30, 2026, with 62.28% growth. This brings the company's revenue in the last twelve months to 589.17M, up 14.91% year-over-year. In the fiscal year ending September 30, 2025, JCY International Berhad had annual revenue of 478.09M, down -21.20%.
Revenue (ttm)
589.17M
Revenue Growth
+14.91%
P/S Ratio
1.98
Revenue / Employee
226.60K
Employees
2,600
Market Cap
1.17B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 478.09M | -128.59M | -21.20% |
| Sep 30, 2024 | 606.68M | 131.32M | 27.62% |
| Sep 30, 2023 | 475.37M | -355.27M | -42.77% |
| Sep 30, 2022 | 830.64M | -224.61M | -21.29% |
| Sep 30, 2021 | 1.06B | -20.73M | -1.93% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Berjaya Property Berhad | 7.42B |
| Capital A Berhad | 2.61B |
| Duopharma Biotech Berhad | 929.41M |
| MKH Berhad | 796.00M |
| Supermax Corporation Berhad | 737.06M |
| Ajinomoto (Malaysia) Berhad | 708.21M |
| BM GreenTech Berhad | 637.27M |
| NCT Alliance Berhad | 365.40M |